Treatment.com International ( (TSE:TRUE) ) just unveiled an update.
Rocket Doctor has been approved as an in-network provider for New York Medicaid, allowing 6.9 million Medicaid beneficiaries to access its virtual healthcare services. This expansion is expected to enhance healthcare access for 35% of New York’s population, reduce emergency room visits, and improve timely specialist referrals. The partnership with EngageWell, supported by a $1 million grant, aims to further enhance virtual care for aging New Yorkers, addressing healthcare disparities and ensuring comprehensive, on-demand medical care.
More about Treatment.com International
Treatment.com AI Inc. operates in the virtual healthcare industry, offering advanced telehealth services through its platform, Rocket Doctor. The company focuses on providing primary, urgent, and specialty care, aiming to improve healthcare accessibility and reduce emergency room visits.
YTD Price Performance: 15.15%
Average Trading Volume: 7,345
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $18.89M
For detailed information about TRUE stock, go to TipRanks’ Stock Analysis page.